The line centers around a breakthrough super peptide created by No7 and the University of Manchester in the UK. The No7 team conducted blind clinical trials on the novel ingredient that No7 R&D contends “biohacks” the skin’s own natural repair process. The matrix-derived peptide blend contains two brand-new chemical entities, a patent-pending world-first technology that cannot be found in any other product, according to the brand.
Advanced mathematical modeling enabled the development of a potent delivery system that improves peptide penetration; the science has been confirmed through research with the University of Nottingham, according to No7.
The range includes Future Renew Damage Reversal Serum, which is said to reverse visible signs of skin damage in four weeks; Future Renew Damage Reversal Night Cream; Future Renew Damage Reversal Eye Serum; and Future Renew Damage Reversal Day Cream with SPF.
Patent applications have been submitted and are pending for both the new peptides and the delivery system found within the serum.
Additional workhorse components in the four-product line include rice proteins, a vitamin C antioxidant blend, hyaluronic acid and niacinamde.
Unlike retinoic acid, No7 says its new super peptide is both highly potent and highly tolerated, being suitable even for those with sensitive skin. This paves the way to highly effective skincare being available to even more people, according to the brand.